Safety, pharmacokinetics, and pharmacodynamic properties of oral DEBIO1143 (AT-406) in patients with advanced cancer: results of a first-in-man study by Hurwitz, Herbert I., Smith, David C., Pitot, Henry C., Brill, Jeffrey M., Chugh, Rashmi, Rouits, Elisabeth, Rubin, Joseph, Strickler, John, Vuagniaux, Gregoire, Sorensen, J. Mel, Zanna, Claudio

Get full text

Oral Debio1143 (AT406), an Antagonist of Inhibitor of Apoptosis Proteins, Combined With Daunorubicin and Cytarabine in Patients With Poor-Risk Acute Myeloid Leukemia—Results of a P... by DiPersio, John F, Erba, Harry P, Larson, Richard A, Luger, Selina M, Tallman, Martin S, Brill, Jeffrey M, Vuagniaux, Gregoire, Rouits, Elisabeth, Sorensen, J. Mel, Zanna, Claudio

Get full text

A Phase I Study of Raltitrexed, an Antifolate Thymidylate Synthase Inhibitor, in Adult Patients with Advanced Solid Tumors by GREM, J. L, SORENSEN, J. M, GOLDSPIEL, B, JOHNSTON, P. G, ALLEGRA, C. J, CULLEN, E, TAKIMOTO, C. H, STEINBERG, S. M, CHEN, A. P, HAMILTON, J. M, ARBUCK, S. G, MCATEE, N, LAWRENCE, D

Get full text

Oral Debio1143 (AT406), an antagonist of inhibitor of apoptosis proteins, in combination with daunorubicin and cytarabine in patients with poor-risk acute myeloid leukemia - result... by DiPersio, John F., Erba, Harry P., Larson, Richard A., Luger, Selina M., Tallman, Martin S., Brill, Jeffrey M., Vuagniaux, Gregoire, Rouits, Elisabeth, Sorensen, J. Mel, Zanna, Claudio

Get full text

Phase I trial of the matrix metalloproteinase inhibitor BAY12-9566 in patients with advanced solid tumors by HEATH, Elisabeth I, O'REILLY, Seamus, KUMOR, Karen, KENNEDY, Sean, GROCHOW, Louise B, HUMPHREY, Rachel, SUNDARESAN, Pavur, DONEHOWER, Ross C, SARTORIUS, Susan, KENNEDY, M. John, ARMSTRONG, Deborah K, CARDUCCI, Michael A, SORENSEN, J. Mel

Get full text

Clinical use of thymidine as a rescue agent from methotrexate toxicity by GREM, J. L, KING, S. A, MEL SORENSEN, J, CHRISTIAN, M. C

Get full text

A pilot study of γ-1b-interferon in combination with fluorouracil, leucovorin, and α-2a-interferon by GREM, J. L, MCATEE, N, ARBUCK, S. G, LAWRENCE, D, PANG, J, ALLEGRA, C. J, MURPHY, R. F, BALIS, F. M, CULLEN, E, CHEN, A. P, HAMILTON, J. M, STEINBERG, S. M, QUINN, M, SORENSEN, J. M

Get full text

Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia by Vijayakrishnan, Jayaram, Studd, James, Broderick, Peter, Kinnersley, Ben, Holroyd, Amy, Law, Philip J., Kumar, Rajiv, Allan, James M., Harrison, Christine J., Moorman, Anthony V., Vora, Ajay, Roman, Eve, Rachakonda, Sivaramakrishna, Kinsey, Sally E., Sheridan, Eamonn, Thompson, Pamela D., Irving, Julie A., Koehler, Rolf, Hoffmann, Per, Nöthen, Markus M., Heilmann-Heimbach, Stefanie, Jöckel, Karl-Heinz, Easton, Douglas F., Pharaoh, Paul D. P., Dunning, Alison M., Peto, Julian, Canzian, Frederico, Swerdlow, Anthony, Eeles, Rosalind A., Kote-Jarai, ZSofia, Muir, Kenneth, Pashayan, Nora, Greaves, Mel, Zimmerman, Martin, Bartram, Claus R., Schrappe, Martin, Stanulla, Martin, Hemminki, Kari, Houlston, Richard S.

Get full text

Author Correction: Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia by Vijayakrishnan, Jayaram, Studd, James, Broderick, Peter, Kinnersley, Ben, Holroyd, Amy, Law, Philip J., Kumar, Rajiv, Allan, James M., Harrison, Christine J., Moorman, Anthony V., Vora, Ajay, Roman, Eve, Rachakonda, Sivaramakrishna, Kinsey, Sally E., Sheridan, Eamonn, Thompson, Pamela D., Irving, Julie A., Koehler, Rolf, Hoffmann, Per, Nöthen, Markus M., Heilmann-Heimbach, Stefanie, Jöckel, Karl-Heinz, Easton, Douglas F., Pharaoh, Paul D. P., Dunning, Alison M., Peto, Julian, Canzian, Frederico, Swerdlow, Anthony, Eeles, Rosalind A., Kote-Jarai, Zsofia, Muir, Kenneth, Pashayan, Nora, Greaves, Mel, Zimmerman, Martin, Bartram, Claus R., Schrappe, Martin, Stanulla, Martin, Hemminki, Kari, Houlston, Richard S.

Get full text